Processing

Please wait...

Settings

Settings

1. WO2005067489 - TYPE II DIABETES

Publication Number WO/2005/067489
Publication Date 28.07.2005
International Application No. PCT/US2004/042393
International Filing Date 17.12.2004
Chapter 2 Demand Filed 04.11.2005
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
35
having six-membered rings with one oxygen as the only ring hetero atom
352
condensed with carbocyclic rings, e.g. cannabinols, methantheline
353
3,4-Dihydrobenzopyrans, e.g. chroman, catechin
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7042
Compounds having saccharide radicals and heterocyclic rings
7048
having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
A61K 31/353 (2006.01)
A61K 31/7048 (2006.01)
CPC
A23L 2/02
A23L 2/04
A23L 33/105
A61K 31/353
A61K 31/7048
A61K 36/746
Applicants
  • SU, Chen [US/US]; US
  • PALU, Afa, Kehaati [US/US]; US
  • ZHOU, Bing-Nan [US/US]; US
  • JENSEN, Claude, Jarakae [US/US]; US
Inventors
  • SU, Chen; US
  • PALU, Afa, Kehaati; US
  • ZHOU, Bing-Nan; US
  • JENSEN, Claude, Jarakae; US
Agents
  • KRIEGER, Michael, F. ; Kirton & McConkie 1800 Eagle Gate Tower 60 East South Temple Salt Lake City, UT 84111, US
Priority Data
11/014,30616.12.2004US
60/534,23005.01.2004US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TYPE II DIABETES
(FR) DIABETE DE TYPE II
Abstract
(EN)
The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a nutraceutical composition or treatment formulated with one or more processed Morinda citrifolia products, including TAHITIAN NONI® juice and juice concentrate, as derived from the Indian Mulberry plant.
(FR)
L'invention concerne une formulation naturelle unique et un procédé d'administration correspondant permettant de traiter et de prévenir le diabète, ou plutôt permettant de d'améliorer le traitement du diabète. On utilise ainsi une composition ou un traitement reposant sur une formulation d'un ou plusieurs produits travaillés à base de Morinda citrifolia, y compris le jus TAHITIAN NONI® et le concentré de ce jus, provenant de l'Indian Mulberry.
Latest bibliographic data on file with the International Bureau